「nov」の検索結果
20件：1～5件目を表示
-
千寿製薬株式会社
日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
https://www.senju.co.jp/chinese/ -
千寿製薬株式会社
日 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/chinese/ -
harmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
千寿製薬株式会社
5 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation channel subfamily V m...
http://www.senju.co.jp/english/ -
harmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf